WW 277 (Lithium 450 mg)

Pill imprint WW 277 has been identified as Lithium carbonate extended release 450 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WW 277

Lithium carbonate extended release 450 mg WW 277
Lithium carbonate extended release 450 mg WW 277  Front
Lithium carbonate extended release 450 mg WW 277  Back
Lithium carbonate extended release
Imprint:
WW 277
Strength:
450 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
West-Ward Pharmaceutical Corporation
National Drug Code (NDC):
00143-1277
Inactive Ingredients:
alginic acid
corn starch
magnesium stearate
povidone
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6204 Major Pharmaceuticals
68084-0043 Amerisource Health Services
35356-0506 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)